NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 816.55
+2.30 (0.28%)
Jan 28, 2026, 1:40 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 145.84 billion as of January 27, 2026. Its market cap has decreased by -38.61% in one year.
Market Cap
145.84B
Enterprise Value
116.45B
Revenue
43.90B
Ranking
n/a
PE Ratio
9.48
Stock Price
816.55
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 145.84B, an increase of 33,864.63%. That is a compound annual growth rate of 24.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 145.84B | -9.83% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 337.15B |
| Emcure Pharmaceuticals | 290.20B |
| Gland Pharma | 277.20B |
| Wockhardt | 219.62B |
| Piramal Pharma | 201.05B |
| Eris Lifesciences | 191.94B |
| Alembic Pharmaceuticals | 150.28B |
| Cohance Lifesciences | 145.99B |